REJURAN® I 1x1 ml – Polynucleotide Treatment for Delicate and Periocular Areas
 
REJURAN® I 1x1 ml is a specialised injectable polynucleotide (PN) treatment developed for skin regeneration and improvement in delicate and thin skin areas, particularly the periocular and perioral regions.
 
Part of the REJURAN® regenerative aesthetics range from PharmaResearch, REJURAN® I uses highly purified DNA-derived polynucleotides manufactured using patented DOT™ (DNA Optimizing Technology).
 
Its formulation is designed for precise treatment of delicate areas where improvement in skin quality, elasticity, hydration and fine lines is desired without conventional volumetric augmentation.
 
Technology & Composition
REJURAN® I is manufactured using PharmaResearch's patented DOT™ (DNA Optimizing Technology), developed for the purification and optimisation of polynucleotide material.
 
Composition:
Highly purified Polynucleotides (PN)
DNA-derived biomaterial
Manufactured using patented DOT™ Technology
Biocompatible PN injectable gel
Sterile injectable medical device
 
Packaging
Each package contains:
1 pre-filled syringe of 1 ml
 
Indications & Treatment Areas
REJURAN® I is particularly suited to professional aesthetic treatments involving delicate and thin skin.
Treatment areas may include:
Periocular area
Perioral area
Face
Neck
Décolleté
Hands
 
Treatment objectives may include:
Fine lines and wrinkles
Reduced skin elasticity
Dehydrated or fragile-looking skin
Deterioration in skin texture
Improvement of overall skin quality
Support for tissue restoration and regeneration
 
Clinical Benefits
Specifically suited to delicate facial areas
Supports tissue regeneration
Helps improve skin elasticity and firmness
Supports improved hydration
Helps improve the appearance of fine lines
Supports smoother and healthier-looking skin
Provides progressive skin-quality improvement
Does not primarily create volumetric augmentation
 
Treatment Protocol
REJURAN® I is supplied as a ready-to-use 1 ml pre-filled syringe and does not require reconstitution.
 
Injection technique, treatment depth, dosage, treatment intervals and number of sessions should be determined by the treating healthcare professional according to the manufacturer's current Instructions for Use and individual patient assessment.
 
REJURAN® I must only be administered by appropriately trained and qualified healthcare professionals.
 
Duration of Results
Results develop progressively as skin quality improves following treatment.
 
The duration of improvement varies according to individual skin condition, age, treatment area, treatment protocol and maintenance schedule. Repeat or maintenance treatments may be recommended following professional assessment.
 
Manufacturer & Regulatory Information
Manufacturer: PharmaResearch
Country of Origin: Republic of Korea
Brand: REJURAN®
Variant: REJURAN® I
Product Type: Injectable Polynucleotide (PN) Medical Device
Technology: DOT™ – DNA Optimizing Technology
Presentation: 1x1 ml
Medical Device Class: Class III
CE Marking: CE 2265
Intended for professional medical use according to the manufacturer's Instructions for Use
 
For Professional Use Only
As a trusted distributor within the medical aesthetics sector, AesthiSave® emphasises that all products supplied are intended exclusively for professional use.
These treatments must only be performed by appropriately qualified healthcare professionals with suitable training and clinical experience, ensuring the highest standards of patient safety and care.